✦ LIBER ✦

917 - Phase II trial of topotecan (T) as a continuous intravenous infusion in patients (PTS) with high grade gliomas

✍ Scribed by A. Kyritsis; E.S. Newlands; C.S. Brock; K. Jaeckle; V. Levin; M. Bower; H. Evans; G. Dane; M. DeWitte; W. Yung

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of topotecan as a 21-day

✍ J.P Stevenson; R.M Scher; R Kosierowski; S.C Fox; M Simmonds; K.-S Yao; F Green; 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 70 KB

Phase II Trial of Topotecan by Continuou

✍ G. Thomas Budd; Cathryn Rankin; Laura F. Hutchins; Lucas Wong; Paul J. Petruska; 📂 Article 📅 2002 🏛 Springer US 🌐 English ⚖ 50 KB

Phase II trial of ritonavir/lopinavir in

✍ Manmeet S. Ahluwalia; Carol Patton; Glen Stevens; Tanya Tekautz; Lilyana Angelov 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 192 KB

Phase I/II trial of topotecan given as c

✍ G. Hütter; H. Szélenyi; P. M. Deckert; U. Keilholz; E. Thiel 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 191 KB

A phase I/II trial and pharmacokinetic s

✍ David M. Peereboom; Jeffrey G. Supko; Kathryn A. Carson; Tracy Batchelor; Surasa 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 187 KB

A phase II window trial of procarbazine

✍ Murali M. Chintagumpala; Henry S. Friedman; Clinton F. Stewart; James Kepner; Ro 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 197 KB